Palo Alto Investors »

Verastem shares owned by Palo Alto Investors

Quarter-by-quarter ownership of Verastem (VSTM) shares owned by Palo Alto Investors from 13F filings

Historical chart of Palo Alto Investors investment in Verastem

Tip: Access up to 7 years of quarterly data

All positions including Verastem held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verastem by Palo Alto Investors

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.3M 246k 5.30

More positions owned by Palo Alto Investors

Insmed Com Par $.01 (INSM)
ACADIA Pharmaceuticals (ACAD)
Ptc Therapeutics I (PTCT)
BioMarin Pharmaceutical (BMRN)
United Therapeutics Corporation (UTHR)
Anaptysbio Inc Common (ANAB)
Mirum Pharmaceuticals (MIRM)
Dyne Therapeutics (DYN)
Biogen Idec (BIIB)
Disc Medicine (IRON)
Iovance Biotherapeutics (IOVA)
Syndax Pharmaceuticals (SNDX)
Annexon (ANNX)
Amicus Therapeutics (FOLD)
Novocure Ord Shs (NVCR)

View all positions for Palo Alto Investors

Top funds holding Verastem

Rtw Investments
BlackRock
Deep Track Capital
Armistice Capital
Vanguard Group
Nantahala Capital Management
State Street Corporation
Vanguard Capital Management
Stonepine Capital Management
Foresite Capital Management VI
Millennium Management
Citadel Advisors
Morgan Stanley
Rosalind Advisors
Alyeska Investment Group

View all funds holding Verastem